MiNK Therapeutics (INKT) Earnings Call Transcript

MiNK Therapeutics, Inc. (INKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury • First patients treated in randomized Phase 2 trial C-1300-02 were alive at Day 28, with improved oxygenation, infection contr

SciSparc (SPRC) shares rose ~140% after its TSX Venture subsidiary received conditional approval to buy ~54% of private Israeli CliniQuantum for 56.6M NeuroThera shares (~$9.46M). Co-Diagnostics (CODX) gained ~53% for a third day amid Ebola PCR assay progress. Akari (AKTX) jumped ~38% on ASCO abstract acceptance and new KRAS-mutant synergy data; Outlook (OTLK) rose ~26% ahead of a June FDA resubmission.

Zealand Pharma (ZEAL) and Generate Biomedicines (GENB) partnered to develop AI-driven protein therapeutics for obesity and metabolic diseases. Generate will receive $30M upfront, up to $35M in early milestones, and potential $1.2B in total milestones plus royalties. Zealand Pharma will handle clinical development and commercialization.

China's ChangXin Memory Technologies announced progress on a new DRAM chip design, causing initial declines in memory stocks. U.S. stocks like Seagate, Western Digital, and SanDisk recovered, while Micron and SK Hynix ended lower. Analysts suggest the market overreacted, but memory stocks were already under pressure.

Hycroft Mining reported its highest-grade drill intercept ever: 19.6 meters with 30.49 g/t gold and 1,726.72 g/t silver. The find, including a 1.7-meter section with even higher grades, extends beyond prior high-grade results, suggesting potential resource expansion. Follow-up drilling is ongoing.

American Airlines expanded its deal with SpaceX to equip its entire mainline fleet (1,030+ aircraft) with Starlink satellite internet. Installations begin in 2027. United Airlines also uses Starlink, while Delta chose Amazon's Leo satellites.